1. Home
  2. ADMA vs CRNX Comparison

ADMA vs CRNX Comparison

Compare ADMA & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

HOLD

Current Price

$16.86

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$47.19

Market Cap

4.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADMA
CRNX
Founded
2004
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7B
4.1B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ADMA
CRNX
Price
$16.86
$47.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
9
Target Price
$28.50
$75.78
AVG Volume (30 Days)
2.4M
1.4M
Earning Date
03-02-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
205.35
N/A
EPS
0.86
N/A
Revenue
$488,559,000.00
$1,535,000.00
Revenue This Year
$22.13
$499.13
Revenue Next Year
$24.15
$893.14
P/E Ratio
$20.47
N/A
Revenue Growth
27.63
47.74
52 Week Low
$13.50
$24.10
52 Week High
$25.67
$57.99

Technical Indicators

Market Signals
Indicator
ADMA
CRNX
Relative Strength Index (RSI) 41.64 37.23
Support Level $16.62 $50.84
Resistance Level $18.00 $50.57
Average True Range (ATR) 0.72 2.25
MACD 0.02 -0.97
Stochastic Oscillator 30.71 3.58

Price Performance

Historical Comparison
ADMA
CRNX

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.

Share on Social Networks: